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Exercise for cancer survivors: A reviewL Daroux-Cole1*, R Pettengell2, A Jewell3*
Abstract
IntroductionAs survivorship becomes increas-ingly common with marked improve-ments in the detection and treatment of cancer, the deleterious effects of the disease and its treatment need continued attention. Exercise is de-veloping a valuable role in the cancer-rehabilitation process. Over the past two decades, a substantial amount of research has been done on the effects of exercise for cancer survivors. The aim of this review was to provide an overview of some of the psychological 
and physical benefits of exercise and to explore exercise-induced immune 
function specific to cancer survivors.
DiscussionIt is commonly accepted that physical activity may improve various physi-cal and psychosocial factors in cancer survivors while potentially reducing the rate of recurrence and improv-ing overall survival. Exercise of low-to-moderate intensity is reportedly a feasible and safe option to mediate the effects of medical treatment and may have the ability to attenuate the loss in physical performance typically associated with cancer treatment. 
Most research in this area is specific to breast and prostate cancer, although recent literature is focusing on other 
tumour types. Of recent interest is the immunological response of exercise in cancer survivors, both on and off treatment. The cytokine cascade in response to exercise differs from that induced by infection, which leads to the question of how exercise impacts those who are immunocompromised. 
Although inflammation is linked with the process of tumourigenesis and ex-ercise has been linked with decreased 
inflammation, surprisingly few stud-ies have examined the immunological impact of exercise within the cancer population. 
ConclusionPhysical activity has been found to 
produce beneficial health-related outcomes for cancer survivors, but exercise dose response is still being explored. Further research is needed to clearly identify the immune re-sponse to exercise as experienced by cancer survivors.
IntroductionTreatment outcomes for many can-cers continue to improve with an increasing cohort of long-term dis-ease-free survivors. However, late effects of treatment may impact upon patients’ short- and long-term physical and psychosocial health1,2.  Treatment-related symptoms can last for months or even years post-treatment and may impact upon overall health of the survivor. Cancer patients are often pre-scribed drugs to help minimize side effects of chemotherapy and re-lated treatment, but drug therapy is viewed as a short-term solution that only temporarily resolves debilitat-ing side effects3. Some of the most debilitating physical symptoms as-sociated with treatment are fatigue, anaemia, muscle wasting, reduced balance and coordination4. These 
physical  symptoms can bring about diminished energy and physical per-formance that may reduce overall mood state and quality of life (QoL)4,5. Cognitive functioning may also be impaired after chemotherapy treat-ment; patients reported having trou-ble focusing, reading and driving5. Increasing levels of physical activity may improve various physical6–8 and psychosocial factors in cancer sur-vivors6,9, while positively impacting the rate of recurrence and overall survival8,10,11. Research suggests that low-to-moderate intensity exercise is a feasible and safe option to mediate the effects of medical treatment3,4,12. Endurance exercise training may have the ability to attenuate the loss in physical performance typically as-sociated with cancer treatment13,14.Exercise is developing a valuable role in the cancer-rehabilitation pro-cess15. A review of quantitative data from 82 controlled trials of physical activity interventions for cancer sur-vivors found that exercise was well tolerated both during and after treat-ment (without adverse events)16. This supports the conclusion from a recent American College of Sports Medicine (ACSM) roundtable that exercise training is safe during and after can-cer treatment and may result in en-hanced physical functioning, QoL and reduced cancer-related fatigue (CRF) in several cancer survivor groups17,18. The aim of the current review was to outline some of the psychological and 
physical benefits and explore the po-tential impact of exercise on immune function in cancer survivors.
Discussion
MorbidityA variety of medical complications are often found to be a direct con-sequence of cancer treatment and 
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improvement (minimum 90 min, 3 times per week)41.
Anxiety and Depression
Anxiety and depression afflict 20–50% of cancer patients42,43;  severity 
fluctuates depending on the type of cancer, stage of cancer, treatment choice as well as stress and cop-ing strategies of the patient44. With regular exercise, cancer survivors experience a reduction in depression and anxiety, thus positively impact-ing QoL31,45. Sessions lasting 30 plus minutes in duration for no more than 12 weeks resulted in the largest anxi-ety improvements, although even acute exercise has shown a reduction in anxiety levels41,44,46,47.Depression is estimated to be four times higher in cancer patients than in general population48; 58% of can-cer patients experience symptoms of depression49. Patients and sur-vivors often experience depressive mood immediately upon diagnosis50, which may persist long after treat-
ment has finished51. The response to exercise has often been positive, thereby resulting in a decrease in depressive symptoms52, although a number of studies show no change (although no adverse effects have been reported)53,54. 
FatigueA common side effect of cancer treatment is fatigue55, which con-tinues long after the completion of  treatment in up to 75% of cancer survivors56. Chronic fatigue is often associated with lower levels of physi-cal activity amongst cancer survivors 
(specifically within the first 5 years after treatment)57. CRF is one of the most debilitating and distressing side effects of cancer and treatment58,59. Exercise is useful in reducing CRF18,60, as inactivity con-tributes to fatigue61. Aerobic exercise is effective at reducing fatigue dur-ing41,52,62, and after treatment15,63,64. 
More specifically, aerobic exercise of moderate intensity shows a strong 
resume normal lifestyle activities including employment and hobbies, resulting in improved QoL, greater independence and sense of control.
Quality of Life (QoL)Exercise has a positive effect on a broad range of QoL dimensions in cancer patients31. Appropriately designed exercise interventions are generally associated with posi-tive QoL outcomes in cancer sur-vivors30,32. Exercise is associated with higher QoL and overall life  satisfaction scores amongst breast cancer patients on treatment33. A meta-analysis reported better QoL in cancer survivors who exercised com-pared with those who did not: these results were consistent amongst dif-ferent tumour types (breast, colo-rectal and gynaecologic cancer and lymphoma)30. Another recent meta-
analysis showed that the significant positive impact of exercise on QoL (when compared with control groups and with their baseline levels of QoL) was still present at follow-up32. In-terestingly, exercise dose emerged as an important moderator of QoL; interventions of longer duration and higher aerobic metabolic equivalents (METs) produced greater change in QoL32. Health-related QoL (HRQL), a sub-component of QoL, has become an integral part of exercise interven-tion evaluation as patient perception 
of the benefits of exercise can have a substantial effect on coping and treatment effectiveness34. Research has shown that PA is positively asso-ciated with HRQL across several can-cer groups35,36. 
Overall Mood DisturbanceMood disturbance is common amongst people with cancer37. High mood disturbance is associated with increasing symptoms38 and nega-tively impacts upon functional status and QoL39. Exercise decreases mood disturbance amongst cancer survi-vors40; even walking has shown an 
negatively affect the QoL in cancer survivors. Cancer-related treatments increase the risk of secondary tu-mours and affect other systems such as cardiac, pulmonary, endocrine and immunologic functions8. Cancer patients may be prone to secondary malignancies, obesity and cardiovas-cular diseases (CVDs), all of which are known causes of late-term morbidity and mortality19,20. Evidence suggests death from CVD and diabetes occurs at a higher rate in cancer survivors than in the general population20,21. Exercise has been found to re-duce the risk of cancer recurrence and mortality for some cancer sur-vivors10,22, as well as decrease CVD risk factors by lowering resting blood pressure23 and resting heart rate24 markers of systemic inflamma-
tion, specifically C-reactive protein (CRP)25 and tumour necrosis factor-
alpha (TNF-α)26. Regular exercise offers protection against all-cause mortality26. Emerging observational and clinical data signify the impor-tance of physical activity in solid tu-mour patients and provide increasing evidence that exercise positively im-pacts major clinical endpoints such as rate of infection, rate of recurrence and overall survival8,10,11,22.
Psychosocial impact of exerciseThe psychosocial consequences of a diagnosis and treatment of malig-
nant disease are significant and of-ten protracted. In one study, 22% of 
malignant patients fulfilled the cri-teria for psychiatric illness27. Many studies have found decreased overall QoL, physical function and increased anxiety and depression amongst cancer survivors when compared with their premorbid measures and with healthy adults28. Perceptions of how cancer has affected survivors’ lives may be related to one’s func-tional abilities and QoL29. Exercise can promote adaptation to the many stressors of cancer and related treat-ment both during and after therapy30 whilst enhancing one’s capacity to 
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trend towards reducing chronic fa-tigue in cancer patients41,65,66. In a recent systematic review, survivors of several types of cancer who took part in exercise interventions had reduced CRF levels when compared with their usual care (the greatest re-duction was seen amongst exercising older patients)67. The impact of resistance training on CRF has been recently examined (amongst men with prostate can-cer68. Although both resistance and aerobic exercise reduced fatigue in the short term, resistance exercise generated longer term fatigue re-duction (as well as improved QoL and physical strength)68. CRF levels improve in direct proportion to the intensity of resistance exercise per-formed67. Amongst cancer patients with persistent CRF, a combination of endurance (30-min walking) and resistance/coordination exercises performed weekdays for 3 weeks re-
sulted in significant improvements in mental and physical fatigue scores54.
Transitioning from ‘patient to 
survivor’It is commonly accepted that there may be disrupted adjustment at dif-ferent times during the survivorship experience69. The transition period from the completion of treatment to re-entry into one’s ‘normal’ lifestyle is often burdened with disruption, un-certainty and distress70–72. Once treat-
ment finishes, patients have more time to deal with the psychological struggles of the cancer journey as well as any existing issues from before can-cer diagnosis71,72. Fifty-three percent of survivors reported that their emo-tional needs were harder to cope with than physical needs during the tran-sition period73, suggesting that this time may be particularly important to one’s cancer recovery as it impacts the cancer survivors’ experience of stress, which may exacerbate late effects73. Exercise has been shown to reduce stress and provide many psychologi-
cal benefits to cancer survivors17,74.
Physiological effects of exercise 
training It is widely accepted that regular physical activity protects against a number of physiological disorders including numerous cancers and has been found to enhance health, longevity and well-being beyond the effectiveness of medical treatment75. Improved heart and lung function, skeletal muscle function, improved body composition, increased life ex-pectancy, increased bone mass den-sity and whole-body metabolism are seen with regular exercise; the protective effect of exercise occurs through improved glucose uptake and insulin sensitivity76, lowered blood pressure77, decreased resting heart rate24 and improved blood li-
pid profile75. Adaptation to exercise starts immediately (even with acute exercise), progresses with continued 
exposure and is specific to both train-ing stimuli and genetic make-up78. 
Physical EfficiencyDue to the deleterious effects of can-cer and its treatment, patients often experience a loss of physical capacity. Both chemotherapy and radiothera-py appear to have a negative impact on the cardiorespiratory system79 and muscular function80. Patients are often unable to maintain their pre-disease level of physical activity and functioning and report reduced physical and role functioning due to physical conditions81. Resulting mus-cle atrophy and cardiopulmonary toxicities make physical exercise tax-ing; decreased oxygen uptake can make regular daily activities feel very challenging82.Improvements in aerobic capacity have been observed with exercise, amongst both patients undergoing treatment and those who have com-pleted treatment16,83,84. Functional ability, the measure of an individual’s capability to perform everyday activ-ities, is rated as the most important, yet least possessed dimension of QoL amongst cancer survivors85. By 
making daily tasks easier to perform, aerobic capacity positively impacts functional ability. Various types of ex-ercise interventions, including walk-ing, running, home-based activity, strength, stretching and aerobic pro-grammes, have resulted in improved functional ability, aerobic capacity or physical functioning amongst can-cer patients and survivors41,52,86,87. 
Research findings indicate that both aerobic capacity and ensuing func-tional ability improve with regular participation in physical activity.
Muscle WastingSkeletal muscle is important for physical function, immune func-tion and metabolic regulation and is responsible for a large portion of glucose metabolism. Skeletal mus-cle wasting, a common side effect of cancer treatment88 is often pre-sent (to some degree) at the time of diagnosis, but is more prevalent with advanced malignancies89. Un-fortunately, muscle wasting brings reduced functional ability and weak-ness90,91 and negatively affects re-sponsiveness to treatment (increas-ing morbidity and mortality)92. It is also suggested that muscle atrophy 
during cancer may play a significant role in the development of metabolic syndrome93. Resistance training may reduce 
skeletal muscle wasting (specific to cancer) and stimulate growth in mus-cle strength and mass88; muscular strength gains are common amongst exercising cancer patients and sur-vivors16. In prostate cancer patients for example, resistance training alone has resulted in increased mus-cle mass, reduced treatment-related side effects94 and increased muscle strength68,94. Improved QoL9 and physical performance scores also resulted from resistance training amongst this group94.
Weight Maintenance A number of studies have fo-cused on adiposity in cancer 
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proinflammatory cytokines, TNF-α 
and IL-1β, but these seem not to in-crease with exercise, indicating that the cytokine cascade caused by exer-cise differs from that induced by in-fection (refer to Figure 1)26,118.Both cancer and its treatment (chemotherapy, surgery and radio-therapy) elevate the level of proin-
flammatory cytokines (TNF-α, IL-1 and IL-6)119. Although inflammation is linked with the process of tumour-igenesis120 and exercise has been 
linked with decreased inflammation, surprisingly few studies have exam-ined the immunological impact of exercise within the cancer popula-
tion, specifically in terms of inflam-mation reduction and anti-tumour immunity108. The effect of exercise on tumour progression was examined in a mouse model of breast cancer; the reduction in tumour progression was associated with IL-6, monocyte che-moattractant protein (MCP-1) and spleen weight121. Further research is needed to suggest a relation-ship between exercise and tumour  progression in humans.The ‘2011 Position Statement, Im-mune Function and Exercise (part one)’ reports that the biological mechanisms relating exercise and cancer are not clearly understood 
The mechanism behind the anti-
inflammatory effect of exercise is not fully understood, but it is gen-erally accepted that it results from both acute and chronic exercise110. It is hypothesised that physical ac-tivity causes an increase in the sys-temic levels of some cytokines with 
anti-inflammatory properties110,114. Skeletal muscle, recently been identi-
fied as an endocrine organ, produces and releases cytokines (myokines) upon contraction115. During exercise, the level of circulating IL-6 largely increases (up to 100-fold), IL-10 increases, and levels of circulating cytokine inhibitors (such as IL-1ra and sTNF-R) marginally increase. 
The release of TNF-α and CRP is also impacted by exercise.IL-6 has been referred to as an 
‘inflammatory-responsive’ cytokine because it does not directly induce 
inflammation with exercise116. Ex-ercise-induced increases in IL-6 have been found to decrease plasma 
TNF-α, thus decreasing inflamma-tion by blocking the production of 
TNF-α26,117. Muscle-derived IL-6 can 
decrease the production of TNF-α 
and IL-1 β and therefore may be re-
sponsible for the beneficial effects of exercise on CRF110. The normal re-sponse to infection is an increase in 
and  survivorship95–98, as body  composition changes are common amongst cancer patients97,99,100. Weight gain is an adverse effect of treatment for many cancer types97 and has been associated with an increased risk for recurrence and death101–103 (approximately 30–50% of breast cancer deaths among post-menopausal women can be attribut-ed to being overweight)104. Despite strong evidence of the statistically 
and clinically significant associa-tions between low levels of activity and obesity, and cancer recurrence and death, sedentary lifestyle and obesity remain prevalent amongst cancer survivors103–106. Obesity is associated with insulin resistance in breast107 and prostate cancer patients95,96.
Immune Function and Exercise 
TrainingAs stated in the ‘2011 Position State-ment, Immune Function and Exercise (part one)’, acute and chronic exer-cise affect immune production and function108. It is suggested that the protective effect of exercise may be 
due, in part, to the anti-inflammatory effect of regular exercise mediated by cytokine production and release 
(creating an anti-inflammatory envi-ronment) and/or decreased adipos-ity. Research shows that participants who are sedentary are more suscep-tible to infection and disease than are their healthy counterparts, sug-gesting physical activity enhances immune function109–111. Cancer is associated with chron-
ic low-grade systemic inflamma-tion26; regular exercise produces a 
long-term anti-inflammatory effect. Regular physical activity is inversely related to serum concentration of 
inflammatory markers112, has been found to reduce CRP25 and suppress 
TNF-α production, thereby defend-
ing against TNF- α-induced insulin resistance (low-grade systemic in-
flammation is linked with insulin resistance)26,113. 
Figure 1: Comparison of sepsis-induced verses exercise-induced increases in circulating cytokines. During sepsis, there is a steep increase in circulating 
TNF-α, which is followed by an increase in interleukin (IL)-6. In contrast, during 
exercise, the marked increase in IL-6 is not preceded by elevated TNF-α. From 
Pedersen & Febbraio (2008) with permission from the American Physiological Society (licence 3116880987934).
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and suggest that the impact specific to tumour type is even less clear108. To date, ‘no studies have examined the 
role of exercise in minimizing the im-
munosuppressive environment that is 
created by the presence of the tumour’ (2011 Position Statement, Immune Function and Exercise: part one108). It is suggested that if the anti-tumour protection offered by exercise oc-curs, the results should be evident in immune-mediated diseases such as lymphomas108. The appropriate exercise dose needed to bring about enhanced immunity is still unknown. It has been proposed that immunity responds in an ‘inverted J’ format: As exercise intensity increases, immu-nity improves but only to a point; im-munity begins to decline if exercise is too intense, suggesting that exhaus-tive exercise may suppress immune function and increase susceptibil-ity to disease122. Further research is 
needed to substantiate these  findings.
ConclusionAs survivorship becomes increas-ingly common with marked improve-ments in the detection and treatment of cancer, the deleterious effects of the disease and its treatment need continued attention. Treatment-induced psychological and physical impairment along with the increased risk of secondary malignancies and CVDs substantiate the need for ho-
listic health interventions specific to this population. Physical activity 
has been found to produce beneficial health-related outcomes for cancer survivors, but the exact dose re-sponse is still being explored. 
Abbreviations listACSM, American College of Sports Medicine; CRF, cancer-related fa-tigue; CRP, C-reactive protein; CVD, cardiovascular disease; HRQL, Health-related quality of life; MCP, monocyte chemoattractant protein; MET, metabolic equivalent; QoL, 
quality of life; TNF-α, tumour necro-sis factor-alpha
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